STOK financials
Stoke Therapeutics (STOK) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
STOK income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $184.42M | $184.42M | -$20.59M | -$6.88M | -0.12 |
| 2024 | $36.55M | $36.55M | -$101.37M | -$88.98M | -1.65 |
| 2023 | $8.78M | $8.78M | -$114.77M | -$104.70M | -2.38 |
| 2022 | $12.40M | $12.40M | -$104.36M | -$101.07M | -2.60 |
| 2021 | $0.00 | $0.00 | -$86.06M | -$85.81M | -2.34 |
| 2020 | $0.00 | -$1.93M | -$53.04M | -$52.24M | -1.56 |
- STOK revenue was $184.42M in fiscal 2025, net income -$6.88M.
Updated 2026-11-07 11:54 UTC